CF Industries Other Non-Current Liabilities increased by 0.9% to $340.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $306.00M to $340.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -5.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $387.00M | $337.00M | $251.00M | $658.00M | $676.00M | $642.00M | $375.00M | $365.00M | $341.00M | $288.00M | $314.00M | $303.00M | $271.00M | $270.00M | $301.00M | $306.00M | $323.00M | $322.00M | $337.00M | $340.00M |
| QoQ Change | — | -12.9% | -25.5% | +162.2% | +2.7% | -5.0% | -41.6% | -2.7% | -6.6% | -15.5% | +9.0% | -3.5% | -10.6% | -0.4% | +11.5% | +1.7% | +5.6% | -0.3% | +4.7% | +0.9% |
| YoY Change | — | — | — | — | +74.7% | +90.5% | +49.4% | -44.5% | -49.6% | -55.1% | -16.3% | -17.0% | -20.5% | -6.3% | -4.1% | +1.0% | +19.2% | +19.3% | +12.0% | +11.1% |